US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 1.3100
  • +0.0500+3.97%
Close Jul 15 16:00 ET
  • 1.3295
  • +0.0195+1.49%
Post 19:55 ET
274.57MMarket Cap-5954P/E (TTM)

Akebia Therapeutics Key Stats

Akebia Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

32.61M

-18.49%
EPS(YoY)

-0.09

+40.00%

Buy

Jul 12, 2024

Akebia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 44.712M--
--2024/Q2-- / 49.452M--
May 9, 20242024/Q132.607M / 46.087M--
Mar 14, 20242023/Q456.196M / 55.393M--
Nov 8, 20232023/Q342.046M / 48.183M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 44.712M--
--2024/Q2-- / 49.452M--
May 9, 20242024/Q132.607M / 46.087M--
Mar 14, 20242023/Q456.196M / 55.393M--
Nov 8, 20232023/Q342.046M / 48.183M--

Unlock Free Earnings Estimates

Akebia Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Jul 12, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg